Project deliverable Open Access

SIMCor. Deliverable 7.1: Definition of model output (TUE, M6)

Huberts, Wouter

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="" xmlns="" xsi:schemaLocation="">
  <identifier identifierType="DOI">10.5281/zenodo.6074808</identifier>
      <creatorName>Huberts, Wouter</creatorName>
      <affiliation>Technische Universiteit Eindhoven</affiliation>
    <title>SIMCor. Deliverable 7.1: Definition of model output (TUE, M6)</title>
    <date dateType="Issued">2021-06-30</date>
  <resourceType resourceTypeGeneral="Text">Project deliverable</resourceType>
    <alternateIdentifier alternateIdentifierType="url"></alternateIdentifier>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.6074807</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf"></relatedIdentifier>
    <rights rightsURI="">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
    <description descriptionType="Abstract">&lt;p&gt;The deliverable describes the preliminary definition of the physiological outputs that will be used during virtual patient cohort generation of both heart failure and aortic valve disease patients. We will define clinically measurable outputs that are representative for the patient groups, both before and after, respectively, transcatheter aortic valve implantation (TAVI) or insertion of a pulmonary artery pressure sensor (PAPS). In addition, clinical targets, related to the clinical performance of the implants, are translated to engineering metrics that can be calculated with physiological models. The targets are paravalvular leakage (TAVI), device migration and vessel perforation (PAPS), and thrombosis (TAVI and PAPS). Finally, we will give output ranges based on literature and simulations that have been conducted prior to the start of the project. These output ranges will be used to remove unrealistic virtual patients (i.e., outside the output ranges) during virtual cohort generation.&lt;/p&gt;</description>
    <description descriptionType="Other">SIMCor (In-Silico testing and validation of Cardiovascular IMplantable devices) has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017578.</description>
      <funderName>European Commission</funderName>
      <funderIdentifier funderIdentifierType="Crossref Funder ID">10.13039/100010661</funderIdentifier>
      <awardNumber awardURI="info:eu-repo/grantAgreement/EC/Horizon 2020 Framework Programme - Research and Innovation action/101017578/">101017578</awardNumber>
      <awardTitle>In Silico testing and validation of Cardiovascular Implantable devices</awardTitle>
All versions This version
Views 3131
Downloads 2626
Data volume 25.4 MB25.4 MB
Unique views 2727
Unique downloads 2222


Cite as